Skip to content

Latest

Teva, Allergan complete $39 billion generics deal

Teva, Allergan complete $39 billion generics deal

Teva Pharmaceutical Industries Ltd. has closed its acquisition of the Allergan plc generics business. The companies said Tuesday that under the deal, announced last July, Allergan receives $33.4 billion in cash and 100.3 million shares of Teva stock, valued at $5.

Pharmacy boosts CVS Health in second quarter

Pharmacy boosts CVS Health in second quarter

Rising PBM and specialty pharmacy sales and recently acquired pharmacy businesses lifted revenue at CVS Health Corp. for the second quarter, with adjusted earnings per share topping Wall Street’s consensus forecast. CVS Health said Tuesday that for the second quarter ended June 30, sales climbed 17.

Mylan launches pair of new generics in U.S.

Mylan launches pair of new generics in U.S.

Mylan N.V. this week introduced two new generic drugs in the U.S. market. On Monday, the company announced final Food and Drug Administration approval for dextroamphetamine sulfate extended-release capsules — in dosages of 5 mg, 10 mg and 15 mg — and finasteride tablets 1 mg.

Industry mourns passing of Mars Inc.’s Forrest Mars Jr.

Industry mourns passing of Mars Inc.’s Forrest Mars Jr.

Forrest E. Mars Jr., heir to candy giant Mars Inc. and its former co-president, has died at age 84. Mars Jr., who passed away on July 26, was the eldest son of Audrey and Forrest E. Mars Sr. and the grandson of Frank C. Mars, the founder of Mars Inc. With his brother

CutisPharma appoints chief scientific officer

CutisPharma appoints chief scientific officer

Steven Dinh has joined CutisPharma as executive vice president and chief scientific officer. CutisPharma said Monday that Dinh will play a key role at the company, overseeing its efforts to develop its pipeline of drugs for New Drug Application (NDA) submission to the Food and Drug Administration.

Walgreens starts offering meningitis B vaccines daily

Walgreens starts offering meningitis B vaccines daily

Walgreens has begun providing bacterial meningitis vaccinations at all of its pharmacies and in-store clinics on a walk-in basis. The drug chain said Monday that the new meningitis B vaccines, Bexsero and Trumenba, protect against most strains of serogroup B meningococcal disease.

Implications of final AMP rule for community Rx

Implications of final AMP rule for community Rx

On February 1, 2016, the Centers for Medicare & Medicaid Services (CMS) released its Final Rule interpreting the provisions of the 2010 health care reform law that address the Medicaid Drug Rebate Program (MDRP).

Walgreens digital exec Pellegrini to join Fitbit

Walgreens digital exec Pellegrini to join Fitbit

Walgreens Boots Alliance executive Adam Pelligrini is leaving the company to join activity tracker device maker Fitbit Inc. as vice president of digital health. Fitbit said Monday that Pellegrini is slated to start at the company on Sept. 6.

London Drugs launches its first iOS app

London Drugs launches its first iOS app

London Drugs has enhanced its photo services with the launch of its first-ever iOS app. The western Canada drug chain said its new Photolab app enables customers to easily upload and print photos direct from their iPhone and iPad mobile devices and social media accounts.